Patent ID: 11912674
Assignee: ILDONG PHARMACEUTICAL CO., LTD.
Field: Organic fine chemistry (Chemistry)
Classification: CPC C  A | IPC C

Claim 10:
11. A method for treating or ameliorating metabolic diseases, cholestatic liver diseases, or organ fibrosis, the method comprising:
administering to a subject a therapeutically effective amount of a pharmaceutical composition comprising (i) 3-((2-chloro-4-((5-cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl)methoxy)phenyl)ethynyl)-5-(((2-hydroxyethoxy)carbonyl)amino)benzoic acid, a racemate, an enantiomer, or a diastereoisomer thereof, or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable salt of the racemate, the enantiomer, or the diastereoisomer and (ii) a carrier.